Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

E-Poster Display

1650P - Desmoid type fibromatosis in patients

Date

17 Sep 2020

Session

E-Poster Display

Topics

Tumour Site

Sarcoma

Presenters

Severine Bouttefroy

Citation

Annals of Oncology (2020) 31 (suppl_4): S914-S933. 10.1016/annonc/annonc288

Authors

S. Bouttefroy1, N. Penel2, V. Minard-Colin3, D. Orbach4, A. Le Cesne5, J. Blay6, P. Marec Berard1, C. Verité7, V. Laurence4, S. Piperno-Neumann4, A. Defachelles8, E. Bompas9, C.M. Chevreau10, F. Duffaud11, S. Salas12, M. Morelle13, M. Jean Denis13, A. Italiano14, S. Bonvalot15, N. Corradini1

Author affiliations

  • 1 Oncology, Institute of Pediatric Hematology and Oncology IHOPE, Centre Leon Berard, 69008 - Lyon/FR
  • 2 General Oncology Department, Centre Oscar Lambret, 59020 - Lille/FR
  • 3 Oncology, Department of Pediatric and Adolescent Oncology, Institut Gustave Roussy, Université Paris-Saclay, Villejuif/FR
  • 4 Oncology, Institut Curie, 75005 - Paris/FR
  • 5 Medical Oncology, Gustave Roussy - Cancer Campus, 94805 - Villejuif/FR
  • 6 Medicine Department, Oncology, Centre Léon Bérard, 69008 - Lyon/FR
  • 7 Oncology, Children hospital, Pediatric Oncology, Bordeaux/FR
  • 8 Oncology, Centre Oscar Lambret, Pediatric and AYA oncology unit, Lille/FR
  • 9 Oncology, ICO Institut de Cancerologie de l'Ouest René Gauducheau, 44805 - Saint-Herblain/FR
  • 10 Oncology Department, Institut Universitaire du Cancer -Toulouse- Oncopole, 31059 - Toulouse/FR
  • 11 Oncology, CHU La Timone Adultes, 13385 - Marseille/FR
  • 12 Oncology, Ap-hm, 13005 - Marseille/FR
  • 13 Oncology, Centre Léon Bérard, Evaluation Medicale et Sarcome, 69008 - Lyon/FR
  • 14 Medical Oncology, Institut Bergonie, 33000 - Bordeaux/FR
  • 15 Dept. Surgery, Institut Curie, 75005 - Paris/FR

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 1650P

Background

Desmoid type fibromatosis (DTF) are rare intermediate malignancies with unpredictable becoming. Guidelines recommend active surveillance (AS) first if few symptoms are present.

Methods

The aim of this retrospective multicentric study is to describe the French population of patients <40 years with DTF registered in 2006-2017 in netSARC and CONTICABASE databases.

Results

Of 1526 patients registered, 964 patients were selected (median age (MA) 31 years, 83 children, F/M: 3.3). APC constitutional pathogenic variant was described in 4.6%. Primary tumor sites were abdominal wall (41%), trunk (23%), extremity (19%), mesentery (14%) and head and neck (HN) (3%); Median size was 55mm. MA was higher in patients with abdominal wall and mesentery sites (32 and 31.5 years) than in those with HN site (21 years, p=0.0001). Patients with familial adenomatous polyposis were 3 times more frequent in multifocal DTF group, and in mesenteric primary (p<0.001). Women of childbearing age were more frequent in the group “abdominal wall” than in the other groups (99.5% vs 96.8%, p=0.007) without increase of DTF diagnosis during pregnancy. First line strategy was known for 487 patients: AS (n=189, MA 31 years; treatment needed in a second time in 77 of them) versus front line treatment (n=298, MA 30 years), including most often surgery (280 patients, MA 31 years) or non surgical therapies (systemic treatment n=14, or cryotherapy n=4) (18 patients, MA 15 years, p<0.0001). With a median follow-up of 17 months [0; 142 months], the 1-year progression free survival (PFS) rate was 83.2% [80.2%-85.8%]. In univariate analysis, PFS was worse for young patients, male, tumor≥5cm, extremity and trunk sites, and APC constitutional pathogenic variant status. In multivariate analysis, size ≥5cm (HR=1.447, p=0.0923) and extremity primary (HR=1.6, p=0.0113) remained associated with worse PFS. Among the 487 informative patients, AS was associated with a better PFS (HR=0.694, p=0.0848).

Conclusions

This series of patients identifies age, gender and constitutional related characteristics. AS seems to be a valid first line option. Such databases improve knowledge about risk factors for DTF and highlight the patients requiring care in expert centers.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.